Molecular Diagnosis of Hepatocellular Carcinoma in Egypt

Molecular Assessment of DNA Methylation Biomarkers in Egyptian Hepatocellular carcinoma Patients.

Detection of SMARCB1 gene mutations in Egyptian hepatocellular carcinoma patients using targeted next-generation sequencing: A pilot study

hTERT rs2736098 Genetic Variants and Susceptibility of Hepatocellular Carcinoma with Chronic Hepatitis C in the Egyptian Patients

Evaluation of Circulating MicroRNA 483-5p as a Useful Diagnostic Tool of Hepatocellular Carcinoma in Egyptian Patients

Identification of Circulating Tumor Cells and Chemokine Receptor CCR6 as Noninvasive Biomarkers in Egyptian Patients with Hepatocellular Carcinoma

Association of AURKA Polymorphisms with the Development and Progression of Hepatocellular Carcinoma in Egyptian Patients

Clinicopathological Significance of BRAF V600E Mutation in Egyptian Colorectal Cancer Patients

Next-generation sequencing (NGS) detection of PIK3CA somatic mutations in Hepatocellular carcinoma (HCC) Egyptians

The Link between an Epidermal Growth Factor Gene Functional Polymorphism and Hepatocellular Carcinoma in a Cohort of Hepatitis C Egyptian Patients